Protease-modulating polyacrylate-based hydrogel stimulates wound bed preparation in venous leg ulcers - A randomized controlled trial

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 12, 2014, Pages 1742-1750

  Humbert, P ^a,b   Faivre, B ^a   Veran Y ^c   Debure, C ^d   Truchetet, F ^e   Becherel P A ^f   Plantin, P ^g   Kerihuel, J C ^h   Eming, S A ⁱ   Dissemond, J ^j   Weyandt, G ^k   Kaspar, D ^l   Smola, H ^i,l   Zollner P ^l  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c Hôpital d'Instructions des Armées A Legouest   (France)

^d Paris Descartes University   (France)

^e Hôpital Beauregard   (France)

^f Hôpital Privé d'Antony   (France)

^g Centre Hospitalier Laennec   (France)

^h Vertical   (France)

ⁱ UNIVERSITY OF COLOGNE   (Germany)

^j UNIVERSITY HOSPITAL ESSEN   (Germany)

^k UNIVERSITY OF WÜRZBURG   (Germany)

^l Paul Hartmann AG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; POLYACRYLIC ACID; PROTEASE MODULATING POLYACRYLATE; UNCLASSIFIED DRUG; ACRYLIC ACID RESIN; CARBOPOL 940; HYDROGEL; PEPTIDE HYDROLASE;

AGED; AMORPHOUS HYDROGEL; ARTICLE; CONTROLLED STUDY; FEMALE; GRANULATION TISSUE; HUMAN; HYDROGEL; HYDROGEL DRESSING; LEG ULCER; MAJOR CLINICAL STUDY; MALE; PROTEASE MODULATING POLYACRYLATE BASED HYDROGEL; RANDOMIZED CONTROLLED TRIAL; TISSUE NECROSIS; COMPARATIVE STUDY; MIDDLE AGED; VARICOSE ULCER; VERY ELDERLY; WOUNDS AND INJURIES;

ACRYLIC RESINS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYDROGELS; LEG ULCER; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; VARICOSE ULCER; WOUNDS AND INJURIES;

EID: 84912049409     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12400     Document Type: Article

References (29)

1. O'Meara S, Cullum N, Nelson EA, Dumville JC,. Compression for venous leg ulcers. Cochrane Database Syst Rev 2012; 11: CD000265 LID- 10.1002/14651858.CD
2. Moffatt C, Morison MJ, Pina E,. Wound bed preparation for venous leg ulcers. In:, Moffatt C, editor. Wound bed preparation in practice Oxford, England; 2004: 12-17.
3. Franks PJ, Moffatt CJ, Connolly M, et al,. Factors associated with healing leg ulceration with high compression. Age Ageing 1995; 24: 407-410.
4. Wysocki AB, Staiano-Coico L, Grinnell F,. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993; 101: 64-68.
5. Trengove NJ, Stacey MC, MacAuley S, et al,. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 1999; 7: 442-452.
6. Eming SA, Krieg T, Davidson JM,. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 2007; 127: 514-525.
7. Eming S, Smola H, Hartmann B, et al,. The inhibition of matrix metalloproteinase activity in chronic wounds by a polyacrylate superabsorber. Biomaterials 2008; 29: 2932-2940.
8. Konig M, Vanscheidt W, Augustin M, Kapp H,. Enzymatic versus autolytic debridement of chronic leg ulcers: a prospective randomised trial. J Wound Care 2005; 14: 320-323.
9. Kaspar D, Dehiri H, Tholon N, Smola H, Zöllner P,. Efficacite clinique du pansement irrigo-absorbant Hydroclean Active contenant du polyacrylate superabsorbant dans le traitement des plaies chroniques-Etude observationelle conduite sur 221 patients. Journal des plaies et cicatrisations 2008; 63: 21-24.
10. Oken MM, Creech RH, Tormey DC, et al,. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-655.
11. Bloemen MC, van Zuijlen PP, Middelkoop E,. Reliability of subjective wound assessment. Burns 2011; 37: 566-571. LID-10.1016/j.b
12. Wannous H, Lucas Y, Treuillet S,. Enhanced assessment of the wound-healing process by accurate multiview tissue classification. IEEE Trans Med Imaging 2011; 30: 315-326. LID-10.1109/TMI
13. Wild T, Prinz M, Fortner N, et al,. Digital measurement and analysis of wounds based on colour segmentation. European Surgery 2008; 40: 5-10.
14. Flowers C, Newall N, LKapp S, et al,. Clinician inter-rater reliability using a medical wound imaging system. Wound Practice and Research 2008; 16: 22-31.
15. Gottrup F, Apelqvist J, Price P,. CN-EWMAPOG. Outcomes in controlled and comparative studies on non-healing wounds: recommendations to improve the quality of evidence in wound management. J Wound Care 2010; 19: 237-268.
16. Bassler D, Montori VM, Briel M, Glasziou P, Guyatt G,. Early stopping of randomized clinical trials for overt efficacy is problematic. J Clin Epidemiol 2008; 61: 241-246. LID-10.1016/j.jc
17. Margolis DJ, Berlin JA, Strom BL,. Risk factors associated with the failure of a venous leg ulcer to heal. Arch Dermatol 1999; 135: 920-926.
18. Meaume S, Kerihuel JC, Fromantin I, Teot L,. Workload and prevalence of open wounds in the community: French Vulnus initiative. J Wound Care 2012; 21: 62.
19. Vin F, Teot L, Meaume S,. The healing properties of Promogran in venous leg ulcers. J Wound Care 2002; 11: 335-341.
20. Coulomb B, Couty L, Fournier B, Gogly A, Lafont A,. Evaluation of a NOSF (Nano-Oligosaccharide Factor) Lipido-Colloid-Matrix in an In Vitro Dermal Equivalent Model. In: Conference Proceedings of the European Wound Management Association. EWMA, Lisbon, 2008: P 117.
21. Schmutz JL, Meaume S, Fays S, et al,. Evaluation of the nano-oligosaccharide factor lipido-colloid matrix in the local management of venous leg ulcers: results of a randomised, controlled trial. Int Wound J 2008; 5: 172-182. LID-10.1111/j.1
22. Smeets R, Ulrich D, Unglaub F, Woltje M, Pallua N,. Effect of oxidised regenerated cellulose/collagen matrix on proteases in wound exudate of patients with chronic venous ulceration. Int Wound J 2008; 5: 195-203. LID-10.1111/j.
23. Meaume S, Truchetet F, Cambazard F, et al,. A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers. Wound Repair Regen 2012; 20: 500-511. LID-10.1111/j.1
24. Harris IR, Yee KC, Walters CE, et al,. Cytokine and protease levels in healing and non-healing chronic venous leg ulcers. Exp Dermatol 1995; 4: 342-349.
25. Ishida Y, Kondo T, Kimura A, Matsushima K, Mukaida N,. Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-kappaB activation and a reciprocal suppression of TGF-beta signal pathway. J Immunol 2006; 176: 5598-5606.
26. Bianchi ME,. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007; 81: 1-5.
27. Gohel MS, Windhaber RA, Tarlton JF, Whyman MR, Poskitt KR,. The relationship between cytokine concentrations and wound healing in chronic venous ulceration. J Vasc Surg 2008; 48: 1272-1277.
28. Piccinini AM, Midwood KS,. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm 2010; 2010 pii: 672395. doi: 10.1155/2010/672395.
29. Hirsiger S, Simmen HP, Werner CM, Wanner GA, Rittirsch D,. Danger signals activating the immune response after trauma. Mediators Inflamm 2012; 2012: 315941.